200 related articles for article (PubMed ID: 32014959)
1. A Pre-operative Score to Discriminate Fibroepithelial Lesions of the Breast: Phyllode Tumor or Fibroadenoma?
Mimoun C; Zeller A; Seror J; Majoulet L; Marchand E; Mezzadri M; Cherel P; Place V; Cornelis F; Benifla JL; Rouzier R
Anticancer Res; 2020 Feb; 40(2):1095-1100. PubMed ID: 32014959
[TBL] [Abstract][Full Text] [Related]
2. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
Li JJX; Tse GM
Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
[TBL] [Abstract][Full Text] [Related]
3. Fibroepithelial breast lesions diagnosed by core needle biopsy demonstrate a moderate rate of upstaging to phyllodes tumors.
Marcil G; Wong S; Trabulsi N; Allard-Coutu A; Parsyan A; Omeroglu A; Atinel G; Mesurolle B; Meterissian S
Am J Surg; 2017 Aug; 214(2):318-322. PubMed ID: 28057293
[TBL] [Abstract][Full Text] [Related]
4. Accuracy and clinical implications of pre-operative breast core needle biopsy diagnoses of fibroepithelial neoplasms and sarcomatoid carcinomas.
Ware AD; Argani P; Cimino-Mathews A
Breast Cancer Res Treat; 2019 Nov; 178(1):51-56. PubMed ID: 31332664
[TBL] [Abstract][Full Text] [Related]
5. Development of a Management Algorithm for the Diagnosis of Cellular Fibroepithelial Lesions From Core Needle Biopsies.
Jung J; Kang E; Chae SM; Kim H; Park SY; Yun B; Kim SM; Jang M; Kim SW; Kim EK
Int J Surg Pathol; 2018 Dec; 26(8):684-692. PubMed ID: 29774785
[TBL] [Abstract][Full Text] [Related]
6. [Fibroepithelial tumours of the breast: not always a simple fibroadenoma].
van de Graaf VA; de Raaff CAL; Walter AW; Weimann MN; Vrouenraets BC
Ned Tijdschr Geneeskd; 2017; 161():D886. PubMed ID: 28466794
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis, characteristics, and treatment of breast carcinomas within benign fibroepithelial tumors.
Saimura M; Koga K; Anan K; Mitsuyama S; Tamiya S
Breast Cancer; 2018 Jul; 25(4):470-478. PubMed ID: 29460095
[TBL] [Abstract][Full Text] [Related]
8. Excision of breast fibroepithelial lesions: when is it still necessary?-A 10-year review of a regional centre.
Mousa-Doust D; Dingee CK; Chen L; Bazzarelli A; Kuusk U; Pao JS; Warburton R; McKevitt EC
Breast Cancer Res Treat; 2022 Jul; 194(2):307-314. PubMed ID: 35639263
[TBL] [Abstract][Full Text] [Related]
9. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast.
Resetkova E; Khazai L; Albarracin CT; Arribas E
Breast J; 2010; 16(6):573-80. PubMed ID: 21070433
[TBL] [Abstract][Full Text] [Related]
10. Analysis of histological features in needle core biopsy of breast useful in preoperative distinction between fibroadenoma and phyllodes tumour.
Morgan JM; Douglas-Jones AG; Gupta SK
Histopathology; 2010 Mar; 56(4):489-500. PubMed ID: 20459556
[TBL] [Abstract][Full Text] [Related]
11. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH
Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242
[TBL] [Abstract][Full Text] [Related]
12. Which lesions with a radiological or core biopsy diagnosis of fibroadenoma should be excised?
Lee A; James J; Whisker L; Rakha EA; Ellis IO
Ann R Coll Surg Engl; 2022 May; 104(5):361-366. PubMed ID: 34939848
[TBL] [Abstract][Full Text] [Related]
13. Phyllodes tumours of the breast diagnosed as B3 category on image-guided 14-gauge core biopsy: analysis of 51 cases from a single institution and review of the literature.
Abdulcadir D; Nori J; Meattini I; Giannotti E; Boeri C; Vanzi E; Vezzosi V; Bianchi S
Eur J Surg Oncol; 2014 Jul; 40(7):859-64. PubMed ID: 24612651
[TBL] [Abstract][Full Text] [Related]
14. Core needle biopsy in fibroepithelial tumors: predicting factors for phyllodes tumors.
Reis YN; Maesaka JY; Shimizu C; Soares-Júnior JM; Baracat EC; Filassi JR
Clinics (Sao Paulo); 2021; 76():e2806. PubMed ID: 33886790
[TBL] [Abstract][Full Text] [Related]
15. Determining whether excision of all fibroepithelial lesions of the breast is needed to exclude phyllodes tumor: upgrade rate of fibroepithelial lesions of the breast to phyllodes tumor.
Van Osdol AD; Landercasper J; Andersen JJ; Ellis RL; Gensch EM; Johnson JM; De Maiffe B; Marcou KA; Al-Hamadani M; Vang CA
JAMA Surg; 2014 Oct; 149(10):1081-5. PubMed ID: 25162470
[TBL] [Abstract][Full Text] [Related]
16. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions.
Sim Y; Ng GXP; Ng CCY; Rajasegaran V; Wong SF; Liu W; Guan P; Nagarajan S; Ng WY; Thike AA; Lim JCT; Nasir NDBM; Tan VKM; Madhukumar P; Yong WS; Wong CY; Tan BKT; Ong KW; Teh BT; Tan PH
BMC Med Genomics; 2019 Oct; 12(1):142. PubMed ID: 31647027
[TBL] [Abstract][Full Text] [Related]
17. Upstaging of Fibroepithelial Lesions: A Single-Institution Experience.
Mohan SC; Tseng J; Marumoto A; Angarita S; Dadmanesh F; Amersi F; Giuliano A; Chung A
Ann Surg Oncol; 2022 Apr; 29(4):2193-2199. PubMed ID: 34671884
[TBL] [Abstract][Full Text] [Related]
18. Fibroadenoma versus phyllodes tumor: a vexing problem revisited!
Tummidi S; Kothari K; Agnihotri M; Naik L; Sood P
BMC Cancer; 2020 Jul; 20(1):648. PubMed ID: 32660435
[TBL] [Abstract][Full Text] [Related]
19. Fibroadenoma With Pleomorphic Stromal Giant Cells: It's Not as Bad as It Looks!
Wawire J; Singh K; Steinhoff MM
Int J Surg Pathol; 2017 Aug; 25(5):425-427. PubMed ID: 28413897
[TBL] [Abstract][Full Text] [Related]
20. Artificial intelligence modelling in differentiating core biopsies of fibroadenoma from phyllodes tumor.
Cheng CL; Md Nasir ND; Ng GJZ; Chua KWJ; Li Y; Rodrigues J; Thike AA; Heng SY; Koh VCY; Lim JX; Hiew VJN; Shi R; Tan BY; Tay TKY; Ravi S; Ng KH; Oh KSL; Tan PH
Lab Invest; 2022 Mar; 102(3):245-252. PubMed ID: 34819630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]